Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 52-Week High – Time to Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $11.32 and last traded at $11.2930, with a volume of 91636 shares traded. The stock had previously closed at $10.9150.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 3.5%

The business has a 50 day simple moving average of $9.27 and a 200 day simple moving average of $8.83. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.44 and a quick ratio of 5.74. The stock has a market cap of $19.21 billion, a PE ratio of 14.86, a P/E/G ratio of 1.07 and a beta of 0.19.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. The company had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.88% and a net margin of 41.82%. On average, equities research analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.